CTSO
Cytosorbents
$0.36
$0.00 (0%)Jul 27, 2026
Key metrics
The numbers that frame CTSO today
- Market cap
- $22.61M
- P/E (TTM)
- -1.9
- EV / FCF
- -4.4
- Gross margin
- 71%
- EV / Sales
- 1.2
- ROIC
- -18.6%
- Div yield
- 0%
- Debt / equity
- 13.1
- 52wk Low
- $0.35
- 52wk High
- $1.22
Growth
Revenue and earnings trend for CTSO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CTSO
Is Cytosorbents a good buy?
No. Cytosorbents has mixed quality and poor momentum. The setup is weak overall. Growth looks poor. That could put pressure on the long-term business case. We think Cytosorbents is selling at a very high price.
What is the market capitalization of CTSO?
Cytosorbents's market capitalization is $22.61M.
What is the P/E ratio for CTSO stock?
Cytosorbents's current P/E ratio is -1.9.
What is the 52-week high for CTSO stock?
The 52-week high for Cytosorbents is $1.22. The current close of $0.36 is 70.5% below that high.
What is the 52-week low for CTSO stock?
The 52-week low for Cytosorbents is $0.35. The current close of $0.36 is 2.9% above that low.
Does CTSO stock pay dividends?
Cytosorbents does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CTSO?
Cytosorbents's Debt / Equity ratio is 13.09.